Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 21, 2023
Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy
Everardo Hegewisch-Solloa, Janine E Melsen, Hiranmayi Ravichandran, et al.
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2020
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development
Ansel P Nalin, Jesse J Kowalski, Alexander C Sprague, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2019
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Melanie A Krook, Hannah Barker, Hui-Zi Chen, et al.
The American Journal of Pathology
|
August 21, 2012
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications
Matthew W Anderson, Shuchun Zhao, Aharon G Freud, et al.
Blood Advances
|
July 29, 2018
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma
Bethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, et al.
The Journal of Clinical Investigation
|
September 6, 2018
SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity
Youwei Wang, Jianhong Chu, Ping Yi, et al.
NPJ Precision Oncology
|
September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Leah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Blood
|
November 18, 2006
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells
Brian Becknell, Tiffany L Hughes, Aharon G Freud, et al.
Leukemia & Lymphoma
|
September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia
Leslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
September 21, 2023
Mapping human natural killer cell development in pediatric tonsil by imaging mass cytometry and high-resolution microscopy
Everardo Hegewisch-Solloa, Janine E Melsen, Hiranmayi Ravichandran, et al.
Oncotarget
|
February 6, 2019
Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy
Hui-Zi Chen, Russell Bonneville, Lianbo Yu, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 6, 2020
Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development
Ansel P Nalin, Jesse J Kowalski, Alexander C Sprague, et al.
Prostate Cancer and Prostatic Diseases
|
May 3, 2019
Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer
Melanie A Krook, Hannah Barker, Hui-Zi Chen, et al.
The American Journal of Pathology
|
August 21, 2012
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications
Matthew W Anderson, Shuchun Zhao, Aharon G Freud, et al.
Blood Advances
|
July 29, 2018
Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma
Bethany Mundy-Bosse, Nathan Denlinger, Eric McLaughlin, et al.
The Journal of Clinical Investigation
|
September 6, 2018
SMAD4 promotes TGF-β-independent NK cell homeostasis and maturation and antitumor immunity
Youwei Wang, Jianhong Chu, Ping Yi, et al.
NPJ Precision Oncology
|
September 17, 2024
FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer
Leah Stein, Karthikeyan Murugesan, Julie W Reeser, et al.
Blood
|
November 18, 2006
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells
Brian Becknell, Tiffany L Hughes, Aharon G Freud, et al.
Leukemia & Lymphoma
|
September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemia
Leslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Page
of 9